LACTOSE (INDIA)
Back to Income Statement
|
LACTOSE (INDIA) Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹116 Cr | ₹114 Cr | ₹66 Cr | ₹46 Cr | ₹35 Cr |
What is the latest Revenue of LACTOSE (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹116 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹35 Cr |
How is Revenue of LACTOSE (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹116 Cr | 2.20 | |
| Mar2024 | ₹114 Cr | 73.10 | |
| Mar2023 | ₹66 Cr | 43.22 | |
| Mar2022 | ₹46 Cr | 31.39 | |
| Mar2021 | ₹35 Cr | - | |
Compare Revenue of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹142.5 Cr | 7% | 27.3% | 21.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 7% |
27.3% |
21.9% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses